CONFERENCE AGENDA

 

 

Singapore, 31 March 2020 - 1 April 2020

Schedule

Create your personal agenda –check the favourite icon

Mar 3111:30
Conference pass

Panel: Asia's immunotherapy landscape and lessons learned from international successes

Immunotherapy
Christy Ma, Chief Strategy Officer, SCG Cell Therapy Pte LtdChina
Mar 3111:30
Conference pass

Optimizing clinical trials with real-world data

Clinical Trials
Jamila Joseph, Senior Vice President - Innovative Technologies And Clinical Research, Reliance Life SciencesIndia
Mar 3111:30
Conference pass

Neurotech: the next frontier

Pharma 4.0
Charles Stacey, President And Chief Executive Officer, CerecinSingapore
Mar 3111:30
Conference pass

Moving from market access to patient access from a payer's perspective

Market Access & Pricing
Anand Jha, Managing Director, Ansea Consultants Pte LtdSingapore
Mar 3111:30
Conference pass

Panel: Bio-Entrepreneur Journey - Trials and Tribulations on the Path to Success

Biotech Invest
Mayank Gurnani, Associate Director, NUS Industry Liaison OfficeSingapore
Yen Choo, Associate Professor, Lee Kong Chian School of MedicineSingapore
Anthony Desir, Director, MoexaHong Kong
Mar 3111:50
Conference pass

Minimising failures in clinical trials with the right project management

Clinical Trials
Yongho Oh, Regional Clinical Project Manager And Iss Project Manager, Jpac And China, SanofiSingapore
Mar 3111:50
Conference pass

CURATE.AI: Finding the optimal drugs and dosage

Pharma 4.0
Dean Ho, Co-Founder, KYAN TherapeuticsUnited States
Mar 3112:10
Conference pass

Humanized mouse model: A tool to address human specific questions in biomedical research

Clinical Trials
Qingfeng Chen, Principal Investigator, A-starSingapore
Mar 3112:10
Conference pass

How AI is creating opportunities for pharma

Pharma 4.0
Vikram Shetty, Country Medical Lead, PfizerSingapore
Mar 3112:10
Conference pass

Making antibodies affordable for all

Market Access & Pricing
Pritha Aggarwal, Sr Program Specialist, IAVIIndia
Mar 3114:00
Conference pass

Panel: Accessing capital for scaling up your biotech

Biotech Invest
Tim Xiao, Principal, Delos CapitalHong Kong
Mar 3114:20
Conference pass

Keynote Panel: AI-driven drug discovery

Keynotes
Chris Gibson, Chief Executive Officer And Co-Founder, Recursion PharmaceuticalsUnited States
Mar 3115:40
Conference pass

PKPD considerations for T-cell dependent Bispecifics (TDBs)

Immunotherapy
Saileta Prabhu, Director, Genenetch IncUnited States
Mar 3115:40
Conference pass

Moving from conventional clinical trials to adaptive clinical trials

Clinical Trials
John Patava, Chief Operating Officer, AUM BiosciencesSingapore
Mar 3115:40
Conference pass

Using machine learning for effective manufacturing

Pharma 4.0
Ajay Shrivastava, Sr. General Manager - Operations, Sun Pharmaceutical Industries LimitedIndia
Mar 3115:40
Conference pass

Panel: Real world evidence - Driving a new drug development paradigm

Market Access & Pricing
Finny Liu, Apac Regional Regulatory Policy Lead, RocheSingapore
Mar 3116:00
Conference pass

Panel: Partnering for the next immuno-oncology breakthrough

Immunotherapy
Aaradhana Sadasivam, Senior Intellectual Property Manager, Temasek Life Sciences Laboratory (TLL)Singapore
Stefan Hart, Senior Director, Scientific Innovation Oncology, J&J Innovation CentreSingapore
Mar 3116:00
Conference pass

Challenges in development of biosimilars and biosimilarity assessment - statistical perspective

Clinical Trials
Sophie Tsou, Associate Investigator, Division Of Biostatistics And Bioinformatics, National Health Research InstitutesTaiwan
Mar 3116:00
Conference pass

Advances in precision medicine: Role of AI

Pharma 4.0
Rajiv Rana, Regional Medical Director Asia Pacific, Merck Pte. Ltd.Singapore
Mar 3116:00
Conference pass

Synthetic DNA technologies enable antibody discovery and optimization

Pharma 4.0
Aaron K Sato, Chief Scientific Officer, Biopharma, Twist BioscienceUnited States
Mar 3116:00
Conference pass

Panel: Attracting early stage capital: What are VCs looking for in biotech investments in Asia?

Biotech Invest
Viren Mahurkar, Founder and Chairman, HitchinRock Advisors
Joseph Mocanu, Managing Director, Verge Capital ManagementSingapore
Gavin Teo, General Partner, B Capital GroupUnited States
Rohit Pratap Singh, Vice President, Xeraya Capital Sdn BhdMalaysia
Mar 3116:20
Conference pass

Adaptive designs in early clinical studies

Clinical Trials
Vincenzo Teneggi, Senior Medical Director, EDDC, A*STARSingapore
Mar 3116:20
Conference pass

Accelerating antibody engineering and discovery using synthetic libraries

Pharma 4.0
Cedric Wu, Vice President of R&D, GenScriptUnited States
Mar 3116:40
Conference pass

Driving immuno-oncology with rational antibody discovery

Immunotherapy
Jerome Boyd-Kirkup, Chief Scientific Officer, Hummingbird BioscienceSingapore
Mar 3116:40
Conference pass

AI prediction with CRISPR validation for drug development

Pharma 4.0
Sourabh Banerjee, Senior Scientist II, Engine BiosciencesSingapore
Mar 3117:00
Conference pass

Panel: Transforming clinical trials with technology

Clinical Trials
Jill Wong, Digital Project Manager, Danone Nutricia ResearchSingapore
Mrunalini Jagtap, Data Management Lead, SICS, A*STARSingapore
Jamila Joseph, Senior Vice President - Innovative Technologies And Clinical Research, Reliance Life SciencesIndia
Mar 3117:00
Conference pass

Changing paradigms in drug discovery - combining robotics and AI

Pharma 4.0
Martin-Immanuel Bittner, Co-Founder And Chief Executive Officer, Arctoris LtdUnited Kingdom
Mar 3117:20
Conference pass

Challenges and regulatory considerations in development of complex generics

Pharma 4.0
Nitin Gaikwad, Senior General Manager of Regulatory Affairs, Lupin PharmaceuticalsIndia

Create your personal agenda –check the favourite icon

Apr 109:20
Conference pass

Keynote Panel: Fostering innovation through partnerships

Keynotes
Anand Gautam, Senior Director And Head, External Science And Innovation, Anz And Sea, PfizerAustralia
Melissa Saw, Global Head of Digital Partnerships, BayerUnited States
Damian O'Connell, Chief Executive Officer Experimental Drug Development Centre, A Star - Agency For Science Technology And ResearchSingapore
Saileta Prabhu, Director, Genenetch IncUnited States
Apr 111:40
Conference pass

Drug development – critical need to move beyond single agent therapy

Immunotherapy
Harish Dave, Chief Medical Officer, AUM BiosciencesSingapore
Apr 111:40
Conference pass

An overview of regulatory inspections in Asia

Clinical Trials
Stephanie Liu, Medical, Regulatory And Clinical Quality Assurance (Mrc Qa) Lead, Lundbeck SingaporeSingapore
Apr 111:40
Conference pass

Partnerships to accelerate the pipeline

Pharma 4.0
Birgit Reitmaier, Head Of Access To Innovation Apac, Merck Pte. Ltd.Singapore
Peter Tobin, Regional Medical Director, Immuno Oncology, MerckAustralia
Apr 111:40
Conference pass

Panel: Adapting to the changing market access landscape

Market Access & Pricing
Laurie Kan, Senior Manager, Market Access, Johnson & JohnsonSingapore
Enver Erkan, Country Manager, PfizerSingapore
Apr 111:40
Conference pass

Utility of AI and big data in drug development

Bio Data
Vishal Doshi, Chief Executive Officer, AUM BiosciencesSingapore
Apr 112:00
Conference pass

Panel: Partnering to improve quality in clinical trials

Clinical Trials
Sunil Pandita, MANAGER CLINICAL QUALITY ASSURANCE, Abbott LabSingapore
Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo PharmaIndia
Apr 112:00
Conference pass

Panel: Partnering for the future

Pharma 4.0
James. Garner, Chief Executive Officer And Managing Director, Kazia Therapeutics LimitedAustralia
Jane Liang, Publishing Project Lead, Global Regulatory Operations, PfizerChina
Apr 114:00
Conference pass

The progression of Car-T Therapy in clinical settings

Immunotherapy
Aung Myo, Vice President, Clinical Development, Tessa TherapeuticsSingapore
Apr 114:00
Conference pass

Improving patient engagement with digital therapeutics

Pharma 4.0
Abhishek Shah, Chief Executive Officer, Wellthy TherapeuticsIndia
Apr 114:00
Conference pass

Panel: Fostering homegrown innovation in Southeast Asia - investor & biotech perspectives

Biotech Invest
Moderator: Ogan Gurel, Chief Scientific Officer, Frt, Chief Marketing Officer, Eidware/Soundmind And Visiting Professor, D.G.I.S.T.Republic Of Korea
Wei Ling Goh, Vice President, Xeraya BiologicsSingapore
Timothy Low, Head Of Healthcare, Pavilion Capital InternationalSingapore
Apr 114:20
Conference pass

LioCyx™ : Cell therapy in Asia – Current and future plans

Immunotherapy
Stephen Lim, Chief Operating Officer, Lion TCR Pte LtdSingapore
Apr 114:20
Conference pass

Panel: Using digital therapeutics to drive innovation

Pharma 4.0
Moderator: Evelyn Pang, Manager, L.E.K. ConsultingSingapore
Miguel Rivera, Asia Business Model Transformation Head, Novartis Asia PacificSingapore
Apr 114:40
Conference pass

Application of NK cell and T cell therapy for the treatment of cancer

Immunotherapy
Sarmistha Deb, Chief Scientific Officer, DiponEd BioIntelligenceIndia
Apr 115:00
Conference pass

Global industry adopted clinical project management competencies

Clinical Trials
Lisa Kim, Director of Capstone / Lecturer, Rutgers School of Health ProfessionsRepublic Of Korea
Apr 115:00
Conference pass

How innovation is driving patient centricity: Japan and other perspectives

Pharma 4.0
Yukiko Asaeda, Managing Director, Patientricity MedPartnersJapan
Apr 115:20
Conference pass

Panel: The future of clinical trials in Asia

Clinical Trials
Fiona Wong, Team Leader Clinical Studies Aspac, Danone Nutricia ResearchSingapore
Apr 115:40
Conference pass

How technology is creating new opportunities for patient centricity

Pharma 4.0
Khee Suan Bang, Clinical Study Manager, Digital And Real-World Evidence, Danone Nutricia ResearchSingapore
last published: 13/Nov/19 01:25 GMT

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738